首页 | 本学科首页   官方微博 | 高级检索  
     

链脲佐菌素诱导实验性糖尿病大鼠模型建立的研究
引用本文:沈亚非,徐焱成. 链脲佐菌素诱导实验性糖尿病大鼠模型建立的研究[J]. 实用诊断与治疗杂志, 2005, 19(2): 79-80
作者姓名:沈亚非  徐焱成
作者单位:武汉大学中南医院内分泌科,武汉市,430071
摘    要:目的:研究链脲佐菌素诱导实验性糖尿病大鼠模型的建立,并观察不同途径给药诱导的差异。方法:采用腹 腔注射或尾静脉注射链脲佐菌素,检测空腹血糖及胰岛素。结果:腹腔注射或尾静脉注射组均出现血糖升高、胰岛素下 降,和对照组相比有显著性差异(P<0.01),两组之间无显著性差异(P>0.05)。结论:腹腔注射或尾静脉注射链脲佐菌 素均可诱导实验性糖尿病大鼠模型建立,两种途径无显著性差异。

关 键 词:糖尿病  链脲佐菌素  动物模型  大鼠
文章编号:1672-3457(2005)02-079-02
修稿时间:2004-10-18

Study on experimental diabetes animal model in rats induced by streptozotocin
SHEN Yafei,XU Yancheng. Study on experimental diabetes animal model in rats induced by streptozotocin[J]. Journal of Practical Diagnosis and Therapy, 2005, 19(2): 79-80
Authors:SHEN Yafei  XU Yancheng
Affiliation:SHEN Yafei,XU Yancheng. Department of Endocrinology,Zhongnan Hospital of Wuhan University,Wuhan 430071,China
Abstract:Objective To study the experimental diabetes animal model in rats induced by streptozotocin and explore the difference in different ways. Methods The diabetic model of Wistar rats was duplicated with streptozotocin once introperitoneally or intratailvenously. The blood glucose and plasma insulin levels were detected. Results Blood glucose levels in streptozotocin groups were increased significantly as compared with control group (P < 0. 01). Plasma insulin levels in streptozotocin groups were decreased significantly as compared with control group (P<0. 01), while there was no significant difference between different ways(P>0. 05). Conclusion The diabetic model of Wistar rats could be duplicated with streptozotocin once intrapertoneally or intratailvenously,while there was no significant difference between two ways.
Keywords:Diabetes mellitus  streptozotocin  animal model  rat
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号